Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Lawrence Berger, M.D.

Co-Author

This page shows the publications co-authored by David Berger and Rocco Ricciardi.
Connection Strength

2.250
  1. The time Interval Between the End of Radiotherapy and Surgery Does Not Affect Outcomes in Rectal Cancer. Am Surg. 2021 Oct 11; 31348211047215.
    View in: PubMed
    Score: 0.248
  2. Prognosis of Different Histological Types in Patients with Stage II and III Colon Cancer. J Gastrointest Surg. 2021 Sep 09.
    View in: PubMed
    Score: 0.246
  3. The growing trend for no primary surgery in colorectal cancer. Colorectal Dis. 2021 10; 23(10):2659-2670.
    View in: PubMed
    Score: 0.244
  4. The Use of Single-Agent Versus Multiple-Agent Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Rectal Cancer. J Gastrointest Cancer. 2021 Jul 01.
    View in: PubMed
    Score: 0.243
  5. Is Microsatellite Status Associated With Prognosis in Stage II Colon Cancer With High-Risk Features? Dis Colon Rectum. 2021 05; 64(5):545-554.
    View in: PubMed
    Score: 0.240
  6. Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma. Ann Surg Oncol. 2021 Jun; 28(6):3408-3414.
    View in: PubMed
    Score: 0.232
  7. Adjuvant Chemotherapy Benefits on Patients with Extramural Vascular Invasion in Stages II and III Colon Cancer. J Gastrointest Surg. 2021 08; 25(8):2019-2025.
    View in: PubMed
    Score: 0.231
  8. Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer. Clin Colorectal Cancer. 2020 03; 19(1):e8-e17.
    View in: PubMed
    Score: 0.218
  9. Zip Code-Related Income Disparities in Patients with Colorectal Cancer. Am Surg. 2021 Jun 08; 31348211023435.
    View in: PubMed
    Score: 0.061
  10. Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer. Clin Cancer Res. 2021 Oct 15; 27(20):5586-5594.
    View in: PubMed
    Score: 0.060
  11. Improving staging of rectal cancer in the pelvis: the role of PET/MRI. Eur J Nucl Med Mol Imaging. 2021 04; 48(4):1235-1245.
    View in: PubMed
    Score: 0.058
  12. Octogenarians present with a less aggressive phenotype of colon adenocarcinoma. Surgery. 2020 12; 168(6):1138-1143.
    View in: PubMed
    Score: 0.058
  13. Ten-year survival after pathologic complete response in rectal adenocarcinoma. J Surg Oncol. 2021 Jan; 123(1):293-298.
    View in: PubMed
    Score: 0.058
  14. Clinical impact of PET/MR in treated colorectal cancer patients. Eur J Nucl Med Mol Imaging. 2019 Oct; 46(11):2260-2269.
    View in: PubMed
    Score: 0.053
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.